Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Aceragen, Inc. (HBY) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Aceragen, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 861838.
Total stock buying since 2014: $45,973,435.
Total stock sales since 2014: $20,335,371.
Total stock option exercises since 2014: $9,703,066.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2023 | 26,965 | $38,290 | 273,476 | $423,624 | 3,086,057 | $0 |
| 2021 | 155,000 | $205,750 | 1,732,089 | $3,138,825 | 0 | $0 |
| 2020 | 3,859,448 | $6,037,340 | 90,828 | $255,407 | 0 | $0 |
| 2019 | 0 | $0 | 119,000 | $296,060 | 0 | $0 |
| 2018 | 54,300 | $216,625 | 5,134,343 | $6,472,844 | 20,316,327 | $9,548,673 |
| 2017 | 8,000,000 | $12,000,000 | 4,079,237 | $8,573,776 | 0 | $0 |
| 2016 | 3,332,780 | $6,649,732 | 0 | $0 | 0 | $0 |
| 2015 | 5,333,333 | $19,999,998 | 3,067,013 | $0 | 1,250 | $6,000 |
| 2014 | 210,000 | $825,700 | 7,741,504 | $1,174,835 | 160,599 | $148,393 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2023-08 | 0 | $0 | 3,334 | $1,775 | 0 | $0 |
| 2023-07 | 0 | $0 | 5,818 | $9,103 | 0 | $0 |
| 2023-05 | 26,965 | $38,290 | 264,324 | $412,746 | 0 | $0 |
| 2023-01 | 0 | $0 | 0 | $0 | 3,086,057 | $0 |
| 2021-12 | 10,000 | $6,150 | 0 | $0 | 0 | $0 |
| 2021-06 | 135,000 | $160,650 | 0 | $0 | 0 | $0 |
| 2021-03 | 10,000 | $38,950 | 1,718,663 | $3,083,907 | 0 | $0 |
| 2021-01 | 0 | $0 | 13,426 | $54,918 | 0 | $0 |
| 2020-12 | 69,941 | $127,292 | 37,169 | $160,532 | 0 | $0 |
| 2020-07 | 749,993 | $1,289,987 | 0 | $0 | 0 | $0 |
| 2020-04 | 3,039,514 | $4,620,061 | 0 | $0 | 0 | $0 |
| 2020-01 | 0 | $0 | 53,659 | $94,875 | 0 | $0 |
| 2019-11 | 0 | $0 | 119,000 | $296,060 | 0 | $0 |
| 2018-12 | 34,300 | $105,725 | 0 | $0 | 0 | $0 |
| 2018-08 | 20,000 | $110,900 | 300,000 | $1,741,090 | 0 | $0 |
| 2018-07 | 0 | $0 | 4,634,343 | $4,251,754 | 0 | $0 |
| 2018-03 | 0 | $0 | 0 | $0 | 20,316,327 | $9,548,673 |
| 2018-01 | 0 | $0 | 200,000 | $480,000 | 0 | $0 |
| 2017-12 | 0 | $0 | 2,300,000 | $4,515,519 | 0 | $0 |
| 2017-10 | 8,000,000 | $12,000,000 | 0 | $0 | 0 | $0 |
| 2017-05 | 0 | $0 | 450,815 | $1,018,391 | 0 | $0 |
| 2017-04 | 0 | $0 | 1,328,422 | $3,039,866 | 0 | $0 |
| 2016-10 | 3,258,330 | $6,521,324 | 0 | $0 | 0 | $0 |
| 2016-05 | 34,450 | $49,608 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2023-08-10 | Gowen Maxine | Sale | 51 | .51 | 26 |
| 2023-08-10 | Milano Vincent | Sale | 3,283 | .53 | 1,749 |
| 2023-07-13 | Zein Youssef El (10% Owner) | Sale | 2,213 | 1.54 | 3,408 |
| 2023-07-12 | Zein Youssef El (10% Owner) | Sale | 3,605 | 1.58 | 5,695 |
| 2023-05-17 | Chopra Atul | Sale | 24,800 | 1.34 | 33,157 |
| 2023-05-17 | Zein Youssef El (10% Owner) | Buy | 26,965 | 1.42 | 38,290 |
| 2023-05-16 | Chopra Atul | Sale | 32,436 | 1.42 | 45,896 |
| 2023-05-15 | Chopra Atul | Sale | 78,436 | 1.47 | 115,300 |
| 2023-05-12 | Chopra Atul | Sale | 81,486 | 1.61 | 130,948 |
| 2023-05-11 | Chopra Atul | Sale | 47,166 | 1.85 | 87,445 |
| 2023-01-17 | Taylor John Clayton (Chief Executive Officer) | Option Ex | 1,341,764 | .00 | 0 |
| 2023-01-17 | Salain Daniel (Chief Operating Officer) | Option Ex | 1,341,764 | .00 | 0 |
| 2023-01-17 | Jordan Andrew R (Chief Strategy Officer) | Option Ex | 402,529 | .00 | 0 |
| 2021-12-17 | Kirby John J. (CHIEF FINANCIAL OFFICER) | Buy | 10,000 | .61 | 6,150 |
| 2021-06-18 | Soland Daniel B (CHIEF OPERATING OFFICER) | Buy | 50,000 | 1.19 | 59,500 |
| 2021-06-01 | Dougherty Michael R | Buy | 85,000 | 1.19 | 101,150 |
| 2021-03-25 | Tarka Elizabeth Ann (CHIEF MEDICAL OFFICER) | Sale | 5,018 | 1.35 | 6,779 |
| 2021-03-25 | Lim Bryant David (SVP AND GENERAL COUNSEL) | Sale | 7,630 | 1.36 | 10,376 |
| 2021-03-25 | Kirby John J. (CHIEF FINANCIAL OFFICER) | Sale | 6,250 | 1.42 | 8,875 |
| 2021-03-18 | Zein Youssef El (10% Owner) | Sale | 1,699,765 | 1.80 | 3,057,877 |
| 2021-03-05 | Soland Daniel B (CHIEF OPERATING OFFICER) | Buy | 10,000 | 3.90 | 38,950 |
| 2021-01-12 | Tarka Elizabeth Ann (Chief Medical Officer) | Sale | 1,745 | 4.19 | 7,309 |
| 2021-01-12 | Lim Bryant David (SVP and General Counsel) | Sale | 1,711 | 4.21 | 7,201 |
| 2021-01-12 | Kirby John J. (Chief Financial Officer) | Sale | 1,693 | 4.22 | 7,151 |
| 2021-01-12 | Milano Vincent (President & CEO) | Sale | 3,210 | 4.20 | 13,475 |
| 2021-01-05 | Lim Bryant David (SVP and General Counsel) | Sale | 1,465 | 3.91 | 5,722 |
| 2021-01-05 | Kirby John J. (Chief Financial Officer) | Sale | 862 | 3.90 | 3,361 |
| 2021-01-05 | Milano Vincent (President & CEO) | Sale | 2,740 | 3.90 | 10,699 |
| 2020-12-22 | Milano Vincent (President & CEO) | Sale | 37,169 | 4.32 | 160,532 |
| 2020-12-11 | Zein Youssef El (10% Owner) | Buy | 69,941 | 1.82 | 127,292 |
| 2020-07-13 | Zein Youssef El (10% Owner) | Buy | 749,993 | 1.72 | 1,289,987 |
| 2020-04-07 | Zein Youssef El (10% Owner) | Buy | 3,039,514 | 1.52 | 4,620,061 |
| 2020-01-29 | Zein Youssef El (10% Owner) | Sale | 17,250 | 1.76 | 30,446 |
| 2020-01-28 | Zein Youssef El (10% Owner) | Sale | 12,532 | 1.76 | 22,081 |
| 2020-01-27 | Zein Youssef El (10% Owner) | Sale | 15,000 | 1.77 | 26,550 |
| 2020-01-07 | Lim Bryant David (SVP and General Counsel) | Sale | 1,603 | 1.78 | 2,853 |
| 2020-01-07 | Yingling Jonathan Michael (Chief Scientific Officer) | Sale | 1,742 | 1.78 | 3,100 |
| 2020-01-07 | Kirby John J. (Chief Financial Officer) | Sale | 911 | 1.78 | 1,621 |
| 2020-01-07 | Fletcher Robert C. (Sr. VP, Bus. Dev. & Strategy) | Sale | 1,615 | 1.78 | 2,874 |
| 2020-01-07 | Milano Vincent (President & CEO) | Sale | 3,006 | 1.78 | 5,350 |
| 2019-11-08 | Zein Youssef El (10% Owner) | Sale | 9,000 | 2.44 | 21,960 |
| 2019-11-07 | Zein Youssef El (10% Owner) | Sale | 10,000 | 2.45 | 24,500 |
| 2019-11-06 | Zein Youssef El (10% Owner) | Sale | 100,000 | 2.50 | 249,600 |
| 2018-12-24 | Milano Vincent (President & CEO) | Buy | 15,000 | 2.93 | 43,920 |
| 2018-12-21 | Lim Bryant David (SVP and General Counsel) | Buy | 4,000 | 3.05 | 12,200 |
| 2018-12-20 | Horobin Joanna (Chief Medical Officer) | Buy | 300 | 3.45 | 1,035 |
| 2018-12-19 | Goldberg Mark Alan | Buy | 10,000 | 3.19 | 31,900 |
| 2018-12-19 | Schafer Carol | Buy | 5,000 | 3.33 | 16,670 |
| 2018-08-09 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 55,000 | 6.30 | 346,500 |
| 2018-08-08 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 78,107 | 5.92 | 462,159 |
| 2018-08-07 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 166,893 | 5.59 | 932,431 |
| 2018-08-07 | Geraghty James A (Director) | Buy | 10,000 | 5.58 | 55,800 |
| 2018-08-07 | Milano Vincent (President & CEO) | Buy | 10,000 | 5.51 | 55,100 |
| 2018-07-20 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 492,567 | .86 | 422,622 |
| 2018-07-19 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 556,000 | .88 | 489,280 |
| 2018-07-18 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 1,725,000 | .85 | 1,469,700 |
| 2018-07-17 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 874,505 | .99 | 862,261 |
| 2018-07-16 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 735,771 | 1.01 | 743,864 |
| 2018-07-13 | Pillar Pharmaceuticals Ii, L.p. (10% Owner) | Sale | 250,500 | 1.05 | 264,027 |
| 2018-03-15 | Baker Julian (Director) | Option Ex | 20,316,327 | .47 | 9,548,673 |
| 2018-01-17 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 200,000 | 2.40 | 480,000 |
| 2017-12-15 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 33,830 | 1.91 | 64,513 |
| 2017-12-14 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 1,166,170 | 2.00 | 2,333,506 |
| 2017-12-13 | Pillar Pharmaceuticals Iii, L.p. (10% Owner) | Sale | 1,100,000 | 1.93 | 2,117,500 |
| 2017-10-26 | Baker Julian (Director) | Buy | 8,000,000 | 1.50 | 12,000,000 |
| 2017-05-01 | Zein Youssef El (Director) | Sale | 450,815 | 2.26 | 1,018,391 |
| 2017-04-25 | Zein Youssef El (Director) | Sale | 890,593 | 2.29 | 2,037,676 |
| 2017-04-24 | Zein Youssef El (Director) | Sale | 437,829 | 2.29 | 1,002,190 |
| 2016-10-07 | 667, L.p. (Director) | Buy | 3,250,000 | 2.00 | 6,500,000 |
| 2016-10-03 | Gowen Maxine | Buy | 4,102 | 2.56 | 10,501 |
| 2016-10-03 | Zein Youssef El | Buy | 4,228 | 2.56 | 10,823 |
| 2016-05-12 | Casey Mark J (Senior VP & General Counsel) | Buy | 34,450 | 1.44 | 49,608 |
| 2016-03-15 | Milano Vincent (President & CEO) | Buy | 40,000 | 1.97 | 78,800 |
| 2015-12-15 | Zein Youssef El (Director) | Sale | 232,759 | .00 | 0 |
| 2015-12-14 | Zein Youssef El (Director) | Sale | 300,000 | .00 | 0 |
| 2015-12-11 | Zein Youssef El (Director) | Sale | 2,483,073 | .00 | 0 |
| 2015-12-10 | Zein Youssef El (Director) | Sale | 51,181 | .00 | 0 |
| 2015-03-17 | Zein Youssef El (Director) | Option Ex | 1,250 | 4.80 | 6,000 |
| 2015-02-13 | Baker Bros. Advisors (gp) Llc (Director) | Buy | 5,333,333 | 3.75 | 19,999,998 |
| 2014-12-16 | Zein Youssef El (Director) | Sale | 650,905 | 1.84 | 368,200 |
| 2014-12-15 | Zein Youssef El (Director) | Sale | 290,000 | .00 | 0 |
| 2014-12-12 | Zein Youssef El (Director) | Sale | 260,846 | .00 | 0 |
| 2014-12-12 | Milano Vincent (President and CEO) | Buy | 200,000 | 4.00 | 799,200 |
| 2014-12-11 | Zein Youssef El (Director) | Sale | 713,108 | .00 | 0 |
| 2014-12-10 | Zein Youssef El (Director) | Sale | 351,046 | .00 | 0 |
| 2014-12-09 | Zein Youssef El (Director) | Sale | 1,425,000 | .00 | 0 |
| 2014-09-03 | Zein Youssef El (Director) | Sale | 1,329,700 | .00 | 0 |
| 2014-09-02 | Zein Youssef El (Director) | Sale | 370,300 | .00 | 0 |
| 2014-08-18 | Zein Youssef El (Director) | Sale | 383,294 | .00 | 0 |
| 2014-08-15 | Zein Youssef El (Director) | Sale | 215,934 | .00 | 0 |
| 2014-08-14 | Zein Youssef El (Director) | Sale | 400,772 | .00 | 0 |
| 2014-05-27 | Sullivan Timothy M (VP Development Programs) | Sale | 160,599 | 2.73 | 438,435 |
| 2014-05-27 | Sullivan Timothy M (VP Development Programs) | Option Ex | 160,599 | .92 | 148,393 |
| 2014-05-27 | Geraghty James A (Director) | Buy | 10,000 | 2.65 | 26,500 |
| 2014-05-23 | Abdul-wahab Umari (Director) | Sale | 45,000 | .00 | 0 |
| 2014-05-23 | Zein Youssef El (Director) | Sale | 45,000 | .00 | 0 |
| 2014-05-22 | Abdul-wahab Umari (Director) | Sale | 250,000 | .00 | 0 |
| 2014-05-22 | Zein Youssef El (Director) | Sale | 250,000 | .00 | 0 |
| 2014-05-21 | Abdul-wahab Umari (Director) | Sale | 250,000 | .00 | 0 |
| 2014-05-21 | Zein Youssef El (Director) | Sale | 250,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises of HBY listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Aceragen, Inc. (symbol HBY, CIK number 861838) see the Securities and Exchange Commission (SEC) website.